Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.

Zanardi R, Franchini L, Gasperini M, Perez J, Smeraldi E.

Am J Psychiatry. 1996 Dec;153(12):1631-3.

PMID:
8942464
2.

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.

Lydiard RB, Stahl SM, Hertzman M, Harrison WM.

J Clin Psychiatry. 1997 Nov;58(11):484-91.

PMID:
9413414
3.

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.

Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB.

Biol Psychiatry. 1998 Jul 15;44(2):77-87.

PMID:
9646889
4.

Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.

Zanardi R, Franchini L, Serretti A, Perez J, Smeraldi E.

J Clin Psychiatry. 2000 Jan;61(1):26-9.

PMID:
10695642
5.

Selective serotonin reuptake inhibitors and delusional depression.

Rothschild AJ, Phillips KA.

Am J Psychiatry. 1999 Jun;156(6):977-8. No abstract available.

PMID:
10360159
6.

Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.

Grimsley SR, Jann MW.

Clin Pharm. 1992 Nov;11(11):930-57. Review.

PMID:
1464219
7.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
8.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880
9.

Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.

Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dubé EM.

J Clin Psychiatry. 2002 Jul;63(7):577-84.

PMID:
12143913
10.

Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.

Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC.

J Clin Psychiatry. 2000 Nov;61(11):863-7.

PMID:
11105740
11.

Depression: making the diagnosis and using SSRIs in the older patient.

Reynolds CF 3rd.

Geriatrics. 1996 Oct;51(10):28-34. Review.

PMID:
8863755
12.

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.

Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W.

Arch Gen Psychiatry. 1996 Sep;53(9):777-84.

PMID:
8792754
13.

SSRI optimal dose remains at issue.

Rifkin A.

J Clin Psychiatry. 1997 Feb;58(2):87-8. No abstract available.

PMID:
9062381
14.

A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome.

Mulsant BH, Pollock BG, Nebes RD, Miller MD, Little JT, Stack J, Houck PR, Bensasi S, Mazumdar S, Reynolds CF 3rd.

J Clin Psychiatry. 1999;60 Suppl 20:16-20.

15.
16.

Withdrawal syndromes after paroxetine and sertraline discontinuation.

Fava GA, Grandi S.

J Clin Psychopharmacol. 1995 Oct;15(5):374-5. No abstract available.

PMID:
8830071
17.
18.

Management of depression in real-life settings: knowledge gained from large-scale clinical trials.

Thompson C.

Int Clin Psychopharmacol. 1994 Jun;9 Suppl 3:21-5.

PMID:
7963447
19.
20.

Response to an open trial of a second SSRI in major depression.

Joffe RT, Levitt AJ, Sokolov ST, Young LT.

J Clin Psychiatry. 1996 Mar;57(3):114-5.

PMID:
8617695

Supplemental Content

Support Center